GlassScriptPhysician profile
Jeffrey A Halpert
NPI 1043241938
$5,622.01
in general payments reported to CMS, 2019-2025
25 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $730 · 2021: $188 · 2022: $457 · 2023: $1,912 · 2024: $575 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812 · Travel and Lodging: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.99 |
| Travel and Lodging | $1,400.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,501.96 | 2023 | |
| Smith+Nephew, INC. | $796.92 | 2019-2025 | Grafix Pl, Pico, Vlp Mini-Mod |
| Organogenesis INC. | $437.43 | 2019-2023 | Puraply Antimicrobial, Puraply |
| Medtronic, INC. | $380.41 | 2022-2025 | Hawkone |
| Stryker Corporation | $358.09 | 2019-2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kci USA, INC. | $316.77 | 2019-2022 | |
| Horizon Therapeutics Plc | $267.27 | 2019-2023 | Krystexxa |
| Amgen INC. | $258.20 | 2024 | Krystexxa |
| Medtronic Vascular, INC. | $188.10 | 2019 | |
| Integra Lifesciences Corporation | $185.29 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pfizer INC. | $144.19 | 2019-2020 | |
| Wright Medical Technology, INC. | $132.83 | 2020 | |
| Orthofix Medical, INC. | $129.11 | 2025 | Physio-Stim |
| Abbvie INC. | $124.99 | 2022 | |
| Paratek Pharmaceuticals, INC. | $121.60 | 2025 | Nuzyra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $54.71 | 2019 | |
| Misonix INC | $43.40 | 2020-2021 | |
| Medshape, INC. | $33.97 | 2022 | |
| Treace Medical Concepts, INC. | $29.79 | 2023 | |
| Next Science LLC | $28.51 | 2023 | Blastx, Xperience, Surgx |
| Ibsa Pharma INC. | $24.18 | 2021 | |
| Kerecis Limited | $22.00 | 2021 | |
| Alfasigma USA, INC. | $15.63 | 2020 | |
| Triad Life Sciences INC. | $14.88 | 2022 | |
| Polarityte, INC. | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Halpert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.